Literature DB >> 15885574

Regulation of hematopoietic stem cells by the niche.

Fumio Arai1, Atsushi Hirao, Toshio Suda.   

Abstract

The quiescent state in the cell cycle is thought to be indispensable for the maintenance of hematopoietic stem cells (HSCs). Interaction of HSCs with their particular microenvironments, known as niches, is critical for maintaining the stem cell properties of HSCs, including cell adhesion, survival, and cell division. Hematopoietic stem cells balance quiescence and cell division in the stem cell niche and also maintain the potential for long-term hematopoiesis. We have recently reported that HSCs expressing the receptor tyrosine kinase Tie2 are in the G0 phase and anti-apoptotic, and comprise a side-population (SP) of HSCs, which contacts osteoblasts (OBs), the source of the angiopoietin-1 (Ang-1) ligand for Tie2 in the bone marrow (BM) niche. Tie2/Ang-1 signaling occurs in interactions between HSCs and niche cells. The interaction of Tie2 with Ang-1 in vitro induces tight adhesion of HSCs to stromal cells and is sufficient to maintain the long-term blood-repopulating (LTR) activity of HSCs in vivo by preventing cell division. In addition, Ang-1 enhances the ability of HSCs to become quiescent and induces their adhesion to the bone surface in vivo, resulting in protection of the HSC compartment from stresses suppressing hematopoiesis. These data suggest that the Tie2/Ang-1 signaling pathway plays a critical role in the maintenance of HSCs in the adult BM niche. Ang-1 produced by OBs activates Tie2 on HSCs and promotes tight adhesion of HSCs to the niche, resulting in quiescence and enhanced survival of HSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885574     DOI: 10.1016/j.tcm.2005.03.002

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  20 in total

1.  Systemic signals regulate ageing and rejuvenation of blood stem cell niches.

Authors:  Shane R Mayack; Jennifer L Shadrach; Francis S Kim; Amy J Wagers
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

Review 2.  The stem cell niche in health and leukemic disease.

Authors:  David T Scadden
Journal:  Best Pract Res Clin Haematol       Date:  2007-03       Impact factor: 3.020

Review 3.  Communications between bone cells and hematopoietic stem cells.

Authors:  R L Porter; L M Calvi
Journal:  Arch Biochem Biophys       Date:  2008-04-07       Impact factor: 4.013

Review 4.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 5.  Hematopoietic Stem Cells: Normal Versus Malignant.

Authors:  Dustin Carroll; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

Review 6.  Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.

Authors:  Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-20       Impact factor: 7.638

7.  MLL5 contributes to hematopoietic stem cell fitness and homeostasis.

Authors:  Yan Zhang; Jasmine Wong; Mark Klinger; Mary T Tran; Kevin M Shannon; Nigel Killeen
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

Review 8.  The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis.

Authors:  Monique Bethel; Brahmananda R Chitteti; Edward F Srour; Melissa A Kacena
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

Review 9.  Hematopoietic niche and bone meet.

Authors:  Benjamin J Frisch; Rebecca L Porter; Laura M Calvi
Journal:  Curr Opin Support Palliat Care       Date:  2008-09       Impact factor: 2.302

Review 10.  Stem cells and lineages of the intestine: a developmental and evolutionary perspective.

Authors:  Shigeo Takashima; David Gold; Volker Hartenstein
Journal:  Dev Genes Evol       Date:  2012-11-21       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.